FOXP3 and Abnormal renal physiology: The purpose of our study was to develop a new non-invasive diagnostic tool, based on an accurate analysis of molecular FOXP3 and CTLA-4 mRNA expression pattern in peripheral blood, during the first post-transplant year, capable to predict aTCMR onset, de novo DSA development and renal dysfunction.